Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Randomized, Double-blind, and Intergroup Control Clinical Study to Evaluation on Lot-to-lot Consistency and Immune Persistence of Three Commercial Batches of 23 Valent Pneumococcal Polysaccharide Vaccine

NCT06314867 is registered in ClinicalTrials.gov with Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd as lead sponsor.

NCT NCT06314867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06314867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Randomized, Double-blind, and Intergroup Control Clinical Study to Evaluation on Lot-to-lot Consistency and Immune Persistence of Three Commercial Batches of 23 Valent Pneumococcal Polysaccharide Vaccine
Lead sponsor
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 30, 2023
Completion date
June 30, 2028
Enrollment
990 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers